tiprankstipranks
Trending News
More News >
Genocea Biosciences (GNCAQ)
OTHER OTC:GNCAQ
US Market

Genocea Biosciences (GNCAQ) Income Statement

Compare
735 Followers

Genocea Biosciences Income Statement

Last quarter (Q0 0), Genocea Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Genocea Biosciences's net income was $-15.98M. See Genocea Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 1.64M$ 1.36M$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 900.00K$ 500.00K$ ―$ -700.00K$ ―
EBITDA
$ -30.01M$ -40.74M$ -36.91M$ -25.70M$ -53.75M
Operating Income
$ -52.10M$ -46.99M$ -38.99M$ -39.52M$ -52.64M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -33.20M$ -43.71M$ -38.95M$ -27.81M$ -56.71M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Genocea Biosciences Earnings and Revenue History